Objective:To analyze nonvalvular atrial fibrillation(NVAF)anticoagulation bleeding in patients with risk factors,in order to provide help to predict patients bleeding events.Methods:Clinical data,anti-thrombotic treatment strategies and in-hospital bleeding of 158 NVAF patients hospitalized in The First Affiliated Hospital of Gannan Medical University from March 1,2021 to November 1,2022 were collected.They were divided into anticoagulant bleeding group and anticoagulant non-bleeding group according to whether bleeding occurred.Univariate analysis and multivariate logistic regression analysis were performed for each index of the 2 groups.Results:A total of 158 patients were treated with anticoagulants,including 28 cases(17.72%)in bleeding group and 130 cases in non-bleeding group.Patients with persistent atrial fibrillation(P=0.005),history of statin use(P=0.042),history of β-blocker use(P<0.001),stroke history(P=0.014),coronary heart disease history(P=0.009),low molecular weight heparin(P=0.005),warfarin(P=0.001),dabigatran group(P=0.017),total cholesterol(TC)(P<0.001),low density lipoprotein cholesterol(LDL-C)(P<0.001),creatinine(CRE)(P<0.001),aspartate transaminase(AST)(P<0.001),alanine aminotransferase(ALT)(P<0.001),HAS-BLED score(P=0.006)and neutrophil lymphocyte ratio(NLR)(P=0.049)and other indicators,the difference was statistically significant(P<0.05).Multivariate logistic backward stepwise regression analysis showed that CRE(P<0.001),persistent atrial fibrillation(P=0.005)and β-blocker history(P=0.035)were independent factors affecting bleeding in NVAF patients.Further analysis of predictive diagnostic value indicated that the area under ROC curve of creatinine was 0.892(95%CI 0.836~0.947),which had a high predictive value for bleeding after anticoagulation.Conclusion:High levels of creatinine,persistent atrial fibrillation and β-blocker use are independent factors affecting the occurrence of anticoagulant bleeding in NVAF patients,and the increase of creatinine has a high predictive value for post-anticoagulant bleeding.